Publication | Open Access
Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study
70
Citations
38
References
2021
Year
Our study presents preliminary evidence for the benefit of TMZ chronotherapy to GBM patient survival. This impact is more pronounced in MGMT-methylated patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1